因膀胱过度活动症处方β3肾上腺素能受体激动剂激活棕色脂肪组织导致FDG摄取
本文报告一例老年女性,在FDG PET上出现显著的棕色脂肪组织(BAT)摄取。患者因膀胱过度活动症服用β3肾上腺素能受体激动剂米拉贝隆,疑似该药激活BAT导致明显显影。BAT可产热并发挥冬眠腺作用,儿童或寒冷环境中的瘦削年轻成人中有时可见FDG摄取,嗜铬细胞瘤或副神经节瘤患者因儿茶酚胺作用也可见BAT摄取。
要点
- 因膀胱过度活动症服用β3肾上腺素能受体激动剂米拉贝隆可能激活棕色脂肪组织。
- 棕色脂肪组织激活可导致FDG PET上出现显著摄取,需与肿瘤性摄取鉴别。
- 嗜铬细胞瘤或副神经节瘤患者因儿茶酚胺作用也可见棕色脂肪组织FDG摄取。
核心结论
- 本例老年女性FDG PET上棕色脂肪组织显著摄取,疑似由因膀胱过度活动症处方的β3肾上腺素能受体激动剂米拉贝隆激活所致。
研究设计与样本
- 本文为个案报告。
主要发现
- 一例老年女性在FDG PET上出现显著的棕色脂肪组织摄取。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Brown adipose tissue (BAT), which produces energy and is known to play a role as a hibernating gland, is sometimes visualized on F-FDG PET in children or in slender young adults in a cold environment. Because BAT is activated by catecholamines, FDG uptake in BAT is also observed in patients with pheochromocytoma or paraganglioma. We present the case of an elderly woman with remarkable FDG uptake in BAT. Activation of BAT by a β3-adrenergic receptor agonist (mirabegron) prescribed for overactive bladder was suspected as the cause of the marked visualization of BAT in this patient.
引用
- Okuyama C, Kikuchi R, Ikeuchi T, et al. FDG Uptake in Brown Adipose Tissue Activated by a β3-Adrenergic Receptor Agonist Prescribed for Overactive Bladder. Clin Nucl Med. 2020. PMID: 32453085. doi:10.1097/RLU.0000000000003078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。